当前位置:首页 - 行情中心 - 人福医药(600079) - 财务分析 - 资产负债表

人福医药

(600079)

  

流通市值:301.27亿  总市值:320.11亿
流通股本:15.36亿   总股本:16.32亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金4,104,912,808.594,571,690,025.584,081,166,961.843,228,711,426.9
衍生金融资产8,763,767.812,081,255.5310,816,156.598,898,851.5
应收票据及应收账款8,209,871,089.228,979,833,268.628,849,701,833.338,596,721,132.76
其中:应收票据96,075,06554,746,535.3382,625,003.5179,832,680.47
应收账款8,113,796,024.228,925,086,733.298,767,076,829.828,516,888,452.29
应收款项融资1,350,098,658.62932,121,380.581,122,659,807.85925,414,846.31
预付款项721,239,130.66756,163,252.18758,113,469.18786,378,822.91
其他应收款合计503,201,650.31517,734,164.81537,857,720.15510,497,952.91
其中:应收利息-8,828,990.22--
应收股利-29,437,420.24--
存货3,618,944,898.623,396,429,967.813,379,616,819.663,322,432,456.36
其他流动资产182,073,592.5131,627,138.86117,130,782.06282,301,193.76
流动资产平衡项目0000
流动资产合计19,635,030,670.6720,199,989,726.8319,764,453,634.0618,573,673,268.13
非流动资产:
长期应收款364,355,797.05417,708,704.24413,568,647.24414,829,647.24
长期股权投资1,085,614,045.661,064,772,355.121,085,000,157.651,084,362,355.3
其他权益工具投资586,305,882.87846,406,947.31,834,873,789.21,627,661,847.52
固定资产8,592,189,539.096,867,429,996.316,908,316,020.665,284,061,648.93
在建工程1,833,883,886.451,758,928,710.721,470,756,459.092,974,692,271.4
使用权资产59,766,522.5861,770,565.9967,527,712.7466,488,977.99
无形资产1,914,828,394.931,708,855,600.791,698,015,043.131,917,398,070.01
开发支出669,002,039.21864,139,294.21829,165,042.33829,515,216.17
商誉948,221,747.41974,603,880.59974,712,939.22973,873,424.81
长期待摊费用34,618,138.3832,363,458.7830,547,912.7833,737,818.01
递延所得税资产86,887,980.5470,102,330.8573,489,643.5668,347,426.6
其他非流动资产393,592,922.351,841,353,071.171,765,694,217.151,568,604,489.7
非流动资产平衡项目0000
非流动资产合计16,569,266,896.5216,508,434,916.0717,151,667,584.7516,843,573,193.68
资产平衡项目0000
资产总计36,204,297,567.1936,708,424,642.936,916,121,218.8135,417,246,461.81
流动负债:
短期借款6,712,996,875.377,379,683,935.726,921,328,616.25,924,163,459.55
交易性金融负债--1,092,592.478,219.5
应付票据及应付账款3,212,732,424.53,312,189,149.043,864,782,130.163,606,358,392.52
其中:应付票据495,241,203.79551,463,363.6819,190,186.02852,440,219.09
应付账款2,717,491,220.712,760,725,785.443,045,591,944.142,753,918,173.43
预收款项700,150.14700,150.14308,350,760.79309,850,760.79
合同负债422,848,329.32404,880,486.71427,163,389.97419,626,378.03
应付职工薪酬395,263,983.52251,408,576.04115,929,122.82111,206,155.57
应交税费354,234,306.99341,800,614.53341,206,507.92282,936,602.63
其他应付款合计1,179,810,601.521,521,250,089.791,584,132,148.171,673,198,103.36
应付股利146,403,980.77357,902,687.59359,767,087.5977,277,105.03
一年内到期的非流动负债903,269,362.25803,101,244.191,387,961,241.851,301,588,521.26
其他流动负债44,010,153.5144,454,339.851,246,760.7348,426,943.54
流动负债平衡项目0000
流动负债合计13,225,866,187.1214,059,468,585.9615,003,193,271.0113,677,433,536.75
非流动负债:
长期借款1,665,510,240.291,868,257,771.71,702,555,842.011,784,769,918.07
租赁负债39,552,504.8739,859,288.7646,639,222.346,121,514.14
长期应付款95,121,144.45127,370,298.09127,370,298.09159,054,690.91
递延收益701,986,555.36673,309,931.39677,137,802.5597,879,547.06
递延所得税负债377,648,829.62320,924,322.06396,571,056.3410,763,502.54
非流动负债平衡项目0000
非流动负债合计2,879,819,274.593,029,721,6122,950,274,221.22,998,589,172.72
负债平衡项目0000
负债合计16,105,685,461.7117,089,190,197.9617,953,467,492.2116,676,022,709.47
所有者权益(或股东权益):
实收资本(或股本)1,632,361,0671,632,657,7071,632,657,7071,632,715,541
资本公积5,674,029,879.775,688,431,670.095,789,119,057.345,782,081,854.23
减:库存股87,562,911.7791,405,791.77181,216,105.2182,444,876.93
其他综合收益-22,005,085.6230,415,330.73216,262,513.06159,199,008.51
盈余公积489,525,634.92395,651,769.33395,651,769.33395,651,769.33
未分配利润9,357,251,379.069,084,559,750.918,352,469,629.357,955,182,732.11
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计17,043,599,963.3616,740,310,436.2916,204,944,570.8815,742,386,028.25
少数股东权益3,055,012,142.122,878,924,008.652,757,709,155.722,998,837,724.09
股东权益平衡项目0000
股东权益合计20,098,612,105.4819,619,234,444.9418,962,653,726.618,741,223,752.34
负债和股东权益合计36,204,297,567.1936,708,424,642.936,916,121,218.8135,417,246,461.81
公告日期2024-03-292023-10-272023-08-252023-04-28
审计意见(境内)标准无保留意见
TOP↑